'Developing a new drug is stumbling in the dark without a map. We are building the GPS'

22 mai 2022 | Sagi Cohen
When Immunai, a machine learning firm creating a ‘GPS’ for drug development, was just getting started a leading professor was skeptical about it – now he's their close consultant
 Site référencé:  Haaretz

Haaretz 

Part of new Israeli nature reserve is on Palestinian-owned land
25/05/2022
Despite Turkish FM visit, Israel is still treading lightly with Erdogan
25/05/2022
16-year-old Palestinian killed in clashes with Israeli forces in West Bank
25/05/2022
One leaked tape gives both Bennett and Netanyahu political wins
25/05/2022
Plans for lighting along Eilat beaches endanger coral reefs
25/05/2022
Law on soldiers’ tuition suits Israel's propaganda machine
24/05/2022